Evolent Health, Inc.
EVH· NYSE
Released Nov 9, 2017, after the close
10-Q filed Nov 9, 2017, 40 days after period end · 0001628908-17-000052
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $107.91M | — | — | — |
| Net Income | -$12.59M | -$11.21M | -$11.98M | -$3.17M |
| EPS Diluted | -$0.18 | -$0.26 |
Evolent Health, Inc. · CIK 1628908 · Engraved from SEC EDGAR
| -$0.29 |
| -$2.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.